All Articles

Overview of stem cell-derived islet transplants, trial outcomes, immune-evasion strategies, costs, and timelines for replacing daily insulin in type 1 diabetes.

Islet cell transplants and stem‑cell therapies are shifting diabetes care from lifelong insulin to potential long-term insulin independence.

Overview of prenatal genetic screening and newborn tissue banking: benefits, procedures, costs, and tips for choosing a reputable provider.

Explains Wharton's Jelly, its mesenchymal stem cells, medical uses, and benefits of cord tissue banking for future regenerative therapies.

Stored cord blood stem cells remain viable for decades, treating 80+ conditions—from pediatric cancers to emerging adult regenerative therapies.

FDA-approved expanded cord blood therapies raise stem cell doses, speed neutrophil recovery, reduce infections, broaden donor access, and highlight the need to bank cord blood.

Ex vivo cord blood expansion boosts stem cell counts to speed engraftment, lower infection risk, and enable single‑unit adult transplants.

FDA approvals and nicotinamide expansion make cord blood transplants viable for adults, speeding recovery and lowering infection risk.

Explains how ex vivo stem cell expansion multiplies cord blood HSCs to enable adult transplants, faster engraftment, and broader treatment options.